HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A renal transplant recipient with pulmonary tuberculosis and visceral leishmaniasis: review of superimposed infections and therapy approaches.

Abstract
Visceral leishmaniasis (VL) is an acute or subacute disease that is almost invariably fatal if untreated. It is a rare disease in renal transplant recipients and frequently reported together with other infectious agents. A 39-year-old renal transplant patient was admitted to hospital for elective coronary surgery. In the post-operative period, he developed spiking fever and non-productive cough and his general condition deteriorated. While he was taking medication for non-specific pneumonia, a cavitary lesion occurred in his lung, and he had the diagnosis of pulmonary tuberculosis and antituberculous treatment was started. Despite treatment, his fever continued. As the patient developed pancytopenia and splenomegaly, a bone marrow aspiration was done. Evaluation of bone marrow aspirate indicated Leishmania parasites. He was successfully treated with a more intensive liposomal amphotericin (L-AmB). Complete cure was achieved during follow-up period of 10 months without clinical relapse. In the existence of fever and long-standing pancytopenia, VL should be suspected although the patient had another proved infection and did not live or visit an endemic area. L-AmB usage can be safely preferred for treatment of selected renal transplant recipients with VL as first-line therapy.
AuthorsA Ersoy, M Güllülü, M Usta, T Ozçelik, E Ylmaz, E K Uzaslan, H Vuruskan, M Yavuz, B Oktay, K Dilek, M Yurtkuran
JournalClinical nephrology (Clin Nephrol) Vol. 60 Issue 4 Pg. 289-94 (Oct 2003) ISSN: 0301-0430 [Print] Germany
PMID14579946 (Publication Type: Case Reports, Journal Article)
Topics
  • Adult
  • Coronary Artery Bypass (adverse effects)
  • Coronary Artery Disease (surgery)
  • Humans
  • Kidney Transplantation (adverse effects)
  • Leishmaniasis, Visceral (etiology, therapy)
  • Male
  • Tuberculosis, Pulmonary (etiology, therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: